Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Carcinoma, Hepatocellular × cabozantinib × Clear all

Phase

Status

Completed 8 Recruiting 5 Active not recruiting 3 Withdrawn 2 Not yet recruiting 2 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Renal Cell 2 Neuroendocrine Tumors 1 Neoplasms 1 Differentiated Thyroid Cancer (DTC) 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1

Interventions

Sorafenib 41 lenvatinib 38 sintilimab 21 apatinib 21 camrelizumab 18 Fluorouracil 18 Oxaliplatin 16 tislelizumab 14 Hepatectomy 13 Leucovorin 12 Radiotherapy 10 Radiofrequency Ablation 10 Doxorubicin 10 toripalimab 9 Radiosurgery 9 Folfox protocol 9 Epirubicin 9 Ethiodized Oil 8 Bevacizumab 8 Neoadjuvant Therapy 7 Immune Checkpoint Inhibitors 7 regorafenib 6 pembrolizumab 6 durvalumab 6 anlotinib 6 Nivolumab 6 spartalizumab 5 entecavir 5 donafenib 5 Surgical Procedures, Operative 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04435977 2020-06-17

Immunocabo

Istituto Clinico Humanitas

Phase 2 Unknown

Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡